LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated transcription factors.
Introduction
Head and neck squamous cell carcinomas (HNSCCs) include malignant tumors which arise from the squamous epithelial cells of the oral cavity, nasopharyngeal cavity, paranasal sinuses, salivary glands, and larynx. HNSCC constitutes the sixth most common cancer worldwide with an average 5-year survival rate <50% [1] . Oral cancer is the commonest cancer in the South-East Asia and ranks number one among all other cancers in India with approximate rate 32%-40% of total malignancies diagnosed each year in the Indian subcontinent. The chronic use of chewing tobacco, betel quid, areca nut, stalked lime and paan are common in India present in 90% of cases and has been strongly associated with an increased risk of oral cancer [2] . In addition to the tobacco associated carcinogens, several other factors and viruses mainly certain types of Human Papilloma Virus (HPV) may also play a crucial role in oral tumorigenesis [1] .
Oral cancer originates as a result of the multi-step process with a multifactorial etiology involving various genetic and molecular changes. Oral epithelial cells are affected by various genetic alterations including mutations, Indels and SNV in TP53, NOTCH1, PIK3CA, PTEN, RAS, CASP8, RB, FAT1, TRAF3 and CDKN2A [3, 4, 5] . Various genes of the JAK/STAT, RAS/MAPK and PI3K pathways and, apoptotic gene CASP8 are frequently reported to harbor hot spot mutations in Head and neck cancers [3, 6] . However, mutations in TP53, PIK3CA, NOTCH1 and CASP8 were less frequent in South Indian oral tumors [7, 8] . In addition, Epithelial-mesenchymal transition (EMT), a transdifferentiating mechanism that directs changes in cell states along the epithelial versus mesenchymal axes is a major event in oral cancer progression and metastasis. EMT confers epithelialmesenchymal plasticity upon epithelial cells and the cellular transformation process is orchestrated by a group of transcription factors (TFs), such as the SNAIL, TWIST, and ZEB families [9] . Recently, we reported the role of natural antisense transcript (NAT) for EMT signaling in oral tumors [9] . Therefore, the pathways of carcinogenesis in Indian population might be different from other population which might lead through chromosome instability, telomere lengthening, hormonal activation, environmental factors, chromatin modification, epigenetic changes and dysregulation of non-coding RNAs.
Of late, increasing number of publication showed dysregulation of non-coding RNAs (ncRNAs) in various cancers. Non-coding RNAs are non-protein coding RNA transcripts classified into, microRNAs (miRNAs), a class of shorter ncRNAs with length of ~17-24 nucleotides involved in the regulation of gene expression at post-transcriptional level and long non-coding RNAs (lncRNAs) which are >200 nucleotides in length with limited or no protein-coding capacity, are involved in various cellular mechanism like RNA/DNA, RNA/RNA and RNA/Protein interaction based gene regulation [10] . Deregulation of miRNAs are often reported in many cancers including oral cancer and some of the miRNAs serve as potential biomarkers for detection of early cancer development, disease reoccurrence and prognosis [11] . However, the role of lncRNAs in oral cancer is less understood and increasing number of novel lncRNA transcripts add on the layer of complexity in understanding their role in cancers.
A few lncRNAs including MEG3, PTENP-AS1, PANDAR and GAS5 functions as tumor suppressors and several other lncRNAs are well established to function as oncogenes in various cancers [12] . HOTAIR, linc-ROR, H19, CCAT1, ZEB1-AS1, NEAT1, MALAT1, UCA1 and CDKN2B-AS1 are well documented to be upregulated in oral cancer [12, 14, 15] . LncRNAs function by acting as signals, decoys, guides, and scaffolds and as a repressor or activator of gene transcription and translation. cryano (linc-oip5) is a long intergenic ncRNA, first identified in Zebrafish has been reported to be overexpressed in morula stage of the mouse embryo and maintains stem cell selfrenewal in embryo through modulation of NANOG by sponging Nanog targeting miR-7a [16, 17] . The human counterpart of cryano is OIP5-AS1, which is transcribed from OIP5 gene in antisense orientation and its function in human cancer is yet to be explored. Therefore, in this study, we analyzed the expression of OIP5-AS1 and selected OIP5-AS1 sponged miRNAs and their downstream target genes in sixty oral tumor tissues. We also carried out in-silico epigenomic analysis to understand the function of OIP5-AS1 in oral tumorigenesis.
Results

Patient clinical characteristics
A total of 60 oral squamous cell carcinoma tumors and 8 normal tissue samples were used to study the expression of lncRNAs OIP5-AS1. The mean age of the oral cancer patients is 52.75 ±11.12 and males were predominant (71.6%, n=43). Eighty-one percent of the oral cancer patients were tobacco abusers (n=49) and 11 (65%) and 17 female oral cancer patients used tobacco in smokeless form. Only 18% (n=11) of the individuals developed cancer without the habit of oral cancer associated any risk factors. Eighty percent of the patient presented high tumor grade (>T2 stage) and 96% of them were node positive. About 66% (n=44) of the patients had undifferentiated cellular pathology.
LncRNA OIP5-AS1 is overexpressed in oral tumors with undifferentiated cellular pathology
LncRNA OIP5-AS1 was found to be overexpressed in oral tumors (P <0.001) ( Figure 1A ) and most of the clinical-pathological characters such as age, tobacco abuse, tumor and nodal stages showed an association with OIP5-AS1 expression ( Figure 1B -D). Only cellular differentiation status showed statistical significance (P = 0.0038) with the OIP5-AS1 expression level ( Figure 1E ). Fisher exact test did not show any statistical significance, however, undifferentiated oral tumors displayed higher odds ratio (OR) (2.579 [0.8245 -8.067]) ( Table 1) . Over 67% of the tumors with undifferentiated pathology expressed OIP5-AS1 at a higher level. Further, high-grade tumors with the undifferentiated cellular pathology had significant upregulation (P = 0.0038) of OIP5-AS1 than highgrade tumors with differentiated cellular pathology ( Figure 1F ). Similarly, undifferentiated tumors with tobacco chewing/smoking history showed significant overexpression of OIP5-AS1 (P = 0.0094) ( Figure 1G ). These results suggest an association of OIP5-AS1 with cellular differentiation status of oral tumors.
OIP5-AS1 overexpression is common in human cancers of epithelial origin
To check the OIP5-AS1 expression level in different cancers, we analyzed the human cancer data sets from The Cancer Genome Consortium (TCGA) ( Figure 1I ). We found a high level of OIP5-AS1 expression in tumors of epithelial origin, particularly in Lung, cervical and head and neck cancers. Lung squamous cell carcinoma expressed a significantly higher level of OIP5-AS1 than lung adenocarcinoma. Similarly, renal cell carcinomas also showed overexpression of OIP5-AS1 suggesting its association with the cancers of epithelial origin. Further, testicular germ cell tumors expressed this lncRNAs at very high level in comparison to all other tumors.
Human NANOG is not post-transcriptionally regulated by OIP5-AS1
In the mouse embryo, overexpression of Oip5-as1 (1700020I14Rik) was shown to maintain stemness by regulating the steady state level of NANOG through sponging of mmu-miR-7a [16] [17] [18] .
We hypothesized that OIP5-AS1 might have a similar function in human cancers. Therefore, we checked the conservation of hsa-miR-7-5p and mmu-miR-7 mature sequence and observed 100% sequence similarity between mouse and human ( Figure 2A ). Further, when checked for the conservation of human OIP5-AS1 sequence with mouse Oip5-as1, we observed poor conservation.
However, the binding site for miRNA miR-7 was conserved in OIP5-AS1 ( Figure 2B , Supplementary Figure S1 ).
In mouse, mmu-miR-7a-5p binds to the 3`-UTR of Nanog, regulates its steady state level and signals for cellular differentiation. Overexpressed Oip5-as1 maintains stemness by sponging the mmu-miR-7a-5p [16] . Since the hsa-miR-7a mature sequence is 100% conserved, we checked whether a similar mechanism is taking place in humans. We did a clustal alignment of mouse Nanog and human NANOG mRNA and found that human NANOG 3`-UTR is not conserved and thus no binding site for hsa-miR-7 ( Supplementary Table S1 ). Moreover, when TCGA HNSCC datasets were analyzed for OIP5-AS1 and NANOG co-expression using ChIPBase v2, we did not observe any significant correlation (r = 0.1863).
OIP5-AS1 can sponge miRNAs with tumor suppressive function
Since human NANOG is not regulated by hsa-miR-7a-5p due to lack of binding sites, we asked the question whether the OIP5-AS1 could maintain the cellular stemness by sponging other miRNAs that can post-transcriptionally control stemness associated TFs factors. We did bioinformatics analysis for miRNAs that can be regulated through sponging by OIP5-AS1 and their target genes. We collected the OI5-AS1 target miRNAs predicted by Starbase, DIANA tools and miRcode and identified twelve miRNAs which were targeted by OIP5-AS1 through interaction sites ( Figure 2C ).
For experimental validation in oral tumors, we narrowed down that candidate miRNAs to six (miR-137, miR-148a-3p, miR-30a-5p, miR-30b-5p, miR-338-3p and miR-22-3p) by reviewing the functional evidence present in the literature, analyzing their expression in HNSCC datasets from TCGA and correlating with OIP5-AS1 expression ( Supplementary Table S2 ). For expression studies, along with the 6 miRNAs, miR-140-5p which were shown to control the tumor metastasis in HNSCC and miR-181a-3p, an oral cancer-specific upregulated miRNA that was included as a background control to study lncRNA OIP5-AS1's sponging activity. (For convenience hereafter, we use "miR" to refer human miRNAs)
OIP5-AS1 sponged miRNAs targets chromatin modifiers and RNA binding proteins
To ascertain whether the miRNAs targets stemness associated genes, we predicted the downstream target genes for the 12 miRNAs using TargetScan and miRanda online tools. The results showed that seven genes BCL11A, CELF1, KMT2A, ELAVL2, KMT2C, STYX and TP53INP1 were targeted by all miRNAs (Figure 2D , Supplementary Table S3 ). Further, we constructed a six-set Venn diagram to identify common targets shared by the short-listed 6 miRNAs and identified BCL11A, KMT2A and STYX as a common target for all the predicted miRNAs ( Figure 2E ). However, except miR-137 other miRNAs target all the shortlisted genes.
Similar to the miRNA selection, we reviewed the literature for the association of 7 target genes with cancer and analyzed their expression pattern in HNSCC from TCGA database with reference to OIP5-AS1 expression level (Supplementary Figure S2 ). KMT2A, KMT2C and BCL11A were significantly upregulated in the samples that overexpressed OIP5-AS1 (P = 0.0001, 0.0001 and 0.0001, respectively). We also checked the correlation between the 7 target genes with OIP5-AS1 and found correlation rank r of 0.4383, 0.4289, 0.456 and 0.3384 respectively with significant Pvalues for CELF1, KMT2A, KMT2C, and TP53INP1 (Supplementary Figure S3 ). We also tested the coexpression pattern of OIP5-AS1 with the candidate genes in HNSCC cancer cell line, FANTOM 5 and GTEx studies. The CELF1, KMT2A, and KMT2C showed a positive correlation with OIP5-AS1 expression in many cell types. Further, to understand the functional interactions, we screened for the RNA-binding protein (RBP) binding sites in the 7 target gene transcripts using CLIPdb. The CELF1, KMT2C, and KMT2A had a maximum number of RBP interactions (763, 485 and 296, respectively) and binding sites (37, 34 and 35 respectively) ( Supplementary Table S4 ). In addition, we analyzed the histone modification (HM) signature at candidate gene loci from Roadmap Epigenomics Project HM
ChIP-seq data, gene expression alteration in TFs loss/gain of function from Gene Expression
Omnibus (GEO) and ChIP-Enrichment analysis of stemness associated TFs binding at gene promoter.
Gene loci of CELF1, KMT2A, and KMT2C showed maximum HM signature with significant expression alteration during TFs perturbation and enriched stemness associated TFs binding in various cell types along with OIP5-AS1 (Supplementary Figure S4 , Supplementary Table S5 ). Based on the above results, we selected the three target genes CELF1, KMT2A, and KMT2C for gene expression studies in oral tumors.
Downregulation of OIP5-AS1 sponged miRNAs results in upregulation of downstream target genes
The expression of 6 miRNAs and 3 target genes were analyzed in sixty oral cancer samples.
Out of the 8 selected miRNAs, miR-137, miR-140-5p, miR-148a-3p, miR-30a-5p and miR-338-3p were significantly downregulated in the tumors compared with normal tissue (P <0.001, <0.001, 0.001, 0.001 and 0.0003, respectively) ( Figure 3A ). We further analyzed the expression of miRNAs with reference to cellular differentiation status and observed low-level expression of miRNAs in undifferentiated tumors, and only miR-22-5p and miR-30b-5p expression were statistically significant (P = 0.0485 and 0.0440, respectively). However, the oral cancer specific miRNA, miR-181a-3p was upregulated in the undifferentiated oral tumors ( Figure 3B ).
The candidate genes CELF1, KMT2A and KMT2C were significantly upregulated in oral tumors (P = 0.0417, 0.0248 and 0.018, respectively) ( Figure 3C ). Tumor samples with a high level of OIP5-AS1 showed overexpression of the above genes than the tumors that expressed low levels of OIP5-AS1. Only CELF1 expression was statistically significant (P = 0.0226) ( Figure 3D ). Further, undifferentiated oral tumors expressed a higher level of candidate genes compared to differentiated tumors ( Figure 3E ). Similarly, undifferentiated oral tumors with high levels of OIP5-AS1 overexpressed CELF1, KMT2A, and KMT2C. CELF1 and KMT2A showed statistically significant expression (P = 0.0306 and 0.0341, respectively) ( Figure 3F ).
OIP5-AS1 is under the control of Yamanaka factors
Since OIP5-AS1 is expressed at high level in undifferentiated tumor cells, we asked the question whether the promoter of OIP5-AS1 gene has possible binding motifs for stemness associated TFs (Yamanaka factors) MYC, KLF4, OCT4, SOX2, and NANOG. Therefore, we analyzed the ChIP sequence data from ENCODE database/Roadmap Epigenomics project for TF bindings in both 1kb up and downstream sequence from transcription start site (TSS) of OIP5-AS1 gene. We found a strong association of MYC binding with OIP5-AS1 promoter region ( Figure 4A) . Surprisingly, we also identified several TF binding motifs for MYC, KLF4 and NANOG in the OIP5-AS1 promoter through sequence prediction ( Figure 4B , Supplementary Table S6 ). In addition, we also found several binding motifs for MAX, a functional associate for MYC with which MYC forms heterodimer for DNA binding, in the OIP5-AS1 promoter. Further, to understand the transcriptional activity of the OIP5-AS1 promoter, we analyzed chromatin modification signatures. We observed strong signatures of H3K4me3 and H3K27ac in hESC and cancer cell lines suggesting that the gene was actively transcribed in stem cells and cancer cells. Further, FAIRE-Seq (Formaldehyde-Assisted Isolation of Regulatory Elements) analysis revealed strong regulatory elements binding around the NANOG motif in hESC cell line and MYC motif in cancer cell lines suggesting that NANOG might regulate OIP5-AS1 in hESC and MYC in cancer cells. In addition, H3K27ac/H3K9ac active signature in iPS cells also confirms that OIP5-AS1 could be a downstream effector of Yamanaka factors to maintain stemness (Supplementary Figure S4 ).
OIP5-AS1 could modulate Yamanaka factors through its interacting lncRNAs
As OIP5-AS1 is not directly regulating genes strongly associated with stemness, we analyzed the OIP5-AS1 and other lncRNAs/gene interaction network using RAIN online tool and observed the interaction of the OIP5-AS1 with established chromatin modifiers lncRNAs HOTAIR, TUG1, and NEAT1 ( Figure 4C ). We checked their expression in oral tumors and in HNSCC from TCGA database. Interestingly, all the 3 lncRNAs were upregulated in the oral tumors that overexpressed OIP5-AS1 and showed significant positive correlation with OIP5-AS1 expression (HOTAIRr = 0.678, TUG1r = 0.645 and NEAT1r = 0.346) in TCGA HNSCC datasets ( Figure 4D & 4E ).
There is no report in RAIN database for any functional interaction with Yamanaka factors for the above lncRNAs. However, all the lncRNAs harbor binding sites for miR-143/145 which regulates the Yamanaka factors suggesting that these lncRNAs can collectively maintain stemness in tumors by modulating the Yamanaka factors ( Supplementary Table S7 ).
OIP-AS1 target genes form a functional network
Finally, to understand the importance of the OIP5-AS1 regulated gene function at the molecular level, we constructed a protein-protein interaction network using interaction data from BioGRID database. All the targets showed many individual functional interactions and several common interaction partners between KMT2A, KMT2C, CELF1, ELAVL2 and TP53INP1 ( Figure   5 ). The interaction network showed that the target genes are interacting with several RBPs, chromatin regulatory genes, kinase pathway genes and cancer associated genes. ELAVL1 and BMI1 exhibited a maximum shared interaction between the candidate genes. ELAVL1 shares interactions commonly with the selected candidate genes CELF1, KMT2A and KMT2C. The KMT2A and KMT2C shared maximum interacting partners while CELF1 has maximum interactions with other candidate genes through interacting partners.
OIP5-AS1 complements with OIP5 in maintaining stemness
The OIP5-AS1, an intergenic lncRNA transcribed in antisense orientation of OIP5 gene is overexpressed in oral tumors. We checked the expression of OIP5 in all cancer datasets available in TCGA database. Similar to OIP5-AS1, we observed overexpression of OIP5 gene in squamous cell carcinomas including HNSCC and also in germ-cell tumor (Supplementary Figure S5) . In coexpression analysis, OIP5 was one of the top-most gene found to be co-expressed with OIP5-AS1 in HNSCC than any other cancer (r = 0.5727, P < 0.0001) (Supplementary Figure S6) . Interestingly, unlike OIP5-AS1, OIP5 is not having motifs with stemness TFs binding to its promoter and the activation was independent. Further, we screened the 3`-UTR of OIP5 for any shared microRNA response element (MREs) for the miRNAs those having interaction with OIP5-AS1 and found only miR-424-5p and miR-30a-5p specific MREs in OIP5. Interestingly, we also found many MREs for stemness regulatory miRNAs miR-143/145 family, EMT regulatory miRNA miR-200a/miR-200b/miR-141, TP53 induced miR-34a, let-7, and several other oral cancer specific tumor suppressive miRNAs in OIP5 mRNA 3`-UTR ( Supplementary Table S7 ). These results suggest that OIP5 coexpression could complement OIP5-AS1 function in maintaining stemness in oral cancer.
Discussion
With the advent of next generation sequencing, an abundance of non-coding RNAs have been discovered outnumbering the protein coding RNA transcripts. Non-coding RNA transcript is divided into two major class; microRNAs and long non-coding RNAs depending on the length of the mature transcripts. miRNAs are small non-coding RNAs exert their function at the post-transcriptional level by binding to the 3`-UTRs of the coding mRNAs via a unique seed sequence. Aberration in miRNAs expression was associated with various cancers and diseases has been documented [11, 19, 20] .
Deregulated miRNA expression could alter the post transcriptional regulation of the target genes. One such important function of miR-200 family is regulation of epithelial to mesenchymal transition and miR-143/145 is to maintain the stemness [9, 14] . EMT is an important process by which epithelial cells acquire mesenchymal, fibroblast-like properties during development and accumulating evidence points to a critical role of EMT-like events during tumor progression and malignant transformation by giving the cancer cells the metastatic potential [21] . Synergistically, Cancer stem cells (CSCs), a small niche of cells with self-renewal capacity within the tumor can play an important role in field cancerization [22] . The role of miRNAs in the regulation of EMT and stemness in development and cancer is indispensable; however, the lncRNA's role in cancer development is yet to be explored. LncRNAs, with less or no protein coding potential, are shown to be involved in early embryonic development to cancer metastasis [12, 23] . OIP5-AS1, a long intergenic ncRNA transcribed in antisense from the OIP5 gene, located at chromosome 15q15.1, was first discovered as cyrano in zebrafish and reported to function as a major regulator of neurogenesis during development and in the maintenance of self-renewal in mouse morula stage modulating the nanog expression by sponging mmu-miR-7 [16, 17] . The function of this lncRNA in human development/cancer is not clear and there are only a couple of studies highlighting its role in human cancers. Therefore, we analyzed the expression of OIP5-AS1 in oral cancers of South Indian origin.
In this study, we found overexpression of OIP5-AS1 in oral tumors with undifferentiated cellular pathology and in tumors from the patients with tobacco chewing/smoking history. Our results are consistent with HNSCC datasets from TCGA database and notably, cancers from the squamous epithelial origin and testicular germ cell expressed very high levels of OIP5-AS1. A similar high expression level of OIP5-AS1 has been reported in glioma and shown to be associated with advanced tumor stage and promoted tumor migration through down-regulation of YAP-NOTCH signaling pathway [24] .
In mouse, overexpressed Oip5-as1 sponge the cell differentiation promoting mmu-miR-7a-5p and maintains stemness modulating the nanog level. Therefore, we checked the binding sites for the mouse miRNA counterpart in human (hsa-miR-7-5p), as this particular miRNA is highly conserved across the vertebrates [17] . Though human OIP5-AS1 was poorly conserved, the binding site for hsa-miR-7-5p is preserved at a conserved part of the transcript. To the surprise, the 3'-UTR of human NANOG did not carry any binding site for hsa-miR-7-5p suggesting that NANOG was not targeted by hsa-miR-7-5p. Therefore, we performed a bioinformatics screening and identified 12 miRNAs interacting with OIP5-AS1. Six miRNAs miR-137, miR-148a-3p, miR-338-3p, miR-30a/b-5p and miR-22-3p known to be associated with several cancers were chosen to study the expression levels in oral tumors [20, 25, 26] . Interestingly, all these miRNAs were also reported to be dysregulated in neuronal development and psychiatric disorders [19, 27] .
Expression profiling of the 6 shortlisted miRNAs revealed that most of the miRNAs were downregulated in oral tumors and miR-22-3p and miR-30b-5p were significantly downregulated in undifferentiated tumors. Our results suggest that the predicted miRNAs which are established as tumor suppressors were downregulated in oral tumors and this could be due to the sponging effect of OIP5-AS1. Further, in undifferentiated tumors, OIP5-AS1 alone or together with other lncRNAs might sponge miR-22-3p and miR-30b-5p to a greater extent resulting in the derepression of the downstream target genes. miR-140-5p which has been shown to inhibits cell migration in hypopharyngeal carcinoma did not show any change with reference to tumor differentiation status [28] . Moreover, the commonly upregulated oral cancer specific miR-181a-3p which does not have interaction site with OIP5-AS1 remains upregulated (P=0.0319) in undifferentiated tumors suggesting that the other miRNAs might be tightly regulated by overexpressed OIP5-AS1 through its sponging activity.
Further, we screened the downstream target genes of the 6 miRNAs to check whether any of them targets NANOG. None of the miRNAs could target NANOG or any other well-known stemness related Yamanaka factors (OCT4, SOX2, KLF4, and MYC), however, were found to target epigenetic, metabolic, transport and other development related genes [29] . Seven genes, CELF1, KMT2A, KMT2C, ELAVL2, STYX, BCL11A, and TP53INP1 were the common gene targets for all the 6 miRNAs. We narrowed down the candidates to three (CELF1, KMT2A, and KMT2C) using a six-set Venn diagram of miRNAs with additional parameters like the number of target sites for the 6 miRNAs in 3`-UTR, binding score, the number of RBP interacting sites and reviewing the literature.
We found overexpression of the candidates CELF1, KMT2A, and KMT2C in tumors and particularly in undifferentiated oral tumors. Further, tumors with high levels of OIP5-AS1 also overexpressed the candidate genes and specifically in undifferentiated tumors. CELF1, a RNAbinding protein, binds to GU-rich element (GRE), a regulatory sequence in mRNAs, controls a grid of mRNA transcripts that regulate cell division, proliferation, and apoptosis. Transcripts coding for suppression of cell growth and proliferation are actively targeted by CELF1 protein and upon binding to them, designated for degradation in malignant T-cell [30] . RNA-sequencing identified 1283 mRNA transcripts involved in various cellular pathologies and are differentially regulated due to overexpression of CELF1 and promoted alternative splicing in oral cancer cells [31] . CELF1 protein was reported to be significantly overexpressed in human breast cancer tissues by functioning as a central node controlling translational activation of genes driving EMT and tumor progression [32] .
Overexpression of CELF1 was reported to prevent apoptosis by destabilizing pro-apoptotic mRNAs in oral cancer cells [33] . Loss of CELF1 expression downregulated the MAPK signaling pathway and promoted colorectal cancer cell proliferation and chemoresistance [34] . KMT2A and KMT2C are lysine methyltransferase protein coding genes of mixed-lineage leukemia (MLL) family which encode the nuclear protein with an AT hook DNA-binding domain zinc finger also reported as one of the highly mutated genes in genome level. Dysregulation or mutation of the KMT2 family changes the epigenetic identity of the cells and drives a subset of infantile and adult leukemia [35] . KMT2A contain the CxxC domains that bind to nonmethylated CpG dinucleotides that are highly enriched around TSS and required for active non-coding transcription at enhancers. KMT2A is preferentially expressed in glioma stem cells and downregulation reduces CSC self-renewal and tumorigenicity [36] . KMT2A has been found to interact with the NF-κB pathway to regulate brain cancer growth and promotes melanoma growth by activating the hTERT signaling [37] . Knockdown of KMT2A suppressed tumorsphere formation and the expression of cancer stem cell markers [37] . Similarly, KMT2C is also shown to play roles in metastasis of esophageal squamous cell carcinoma and knockdown experiments showed EMT-like morphological change in pancreatic cancer cell lines [38] .
Decreased expression of KMT2C was associated with attenuated cell proliferation in pancreatic ductal adenocarcinoma and poor outcome in breast cancer [39, 40] . Enrichment of H3K4me3 at promoters of stemness genes OCT4, Nanog and Sox2 were reported during erythroblast erythroid differentiation but completely lost at upon erythroid differentiation [41] . H3K27me3 and H3K4me3 double-positive signals are involved in cell stemness [42] . Therefore, the overexpression of KMT2A and KMT2C could maintain the chromatin active signature and facilitate the maintenance of stemness in cancer stem cells. In addition, overexpressed CELF1 may account for alternative splicing of pre-mRNAs resulting in dominant negative isoforms and destabilization of pro-apoptotic mRNAs there by giving efficiently to the cancer stem cells to create resistance for chemo/radiotherapy.
Since OIP5-AS1 was overexpressed in undifferentiated tumors and associated with maintenance of self-renewal in stem cells, we analyzed the OIP5-AS1 gene promoter region to understand its transcriptional control. We first confirmed the active transcription of the gene by analyzing histone modification signature and DNase-I signature which showed a hyperchromatin activity and hypersensitivity, respectively in hESC and cancer cell lines suggesting the active transcription of OIP5-AS1 during development and cancer. We found several motifs for MYC, NANOG and KLF4 binding in the upstream of TSS and ENCODE data confirmed the binding of TFs, particularly MYC to the OIP5-AS1 promoter. Besides, we also found several motifs for MAX, a known myc-associated factor X protein that forms a heterodimer with MYC and transcriptionally active MAX/MYC heterodimer promotes cell proliferation [43] . In addition, we found strong regulatory binding elements near MYC motif in OIP5-AS1 promoter in undifferentiated myelogenous leukemia cell line. Moreover, we previously reported the upregulation of Yamanaka factors in oral tumors with undifferentiated pathology and MYC co-expression with overexpression of lncRNA CCAT1 in patients with a poor therapeutic response [14, 15] . These findings suggest that the overexpression of OIP5-AS1 might be due to the transcriptional activation of OIP5-AS1 by the stemness associated transcription factors.
In addition, we also screened the expression of established chromatin modifying lncRNAs NEAT1, HOTAIR, and TUG1 [44] , and observed a significant upregulation in oral tumors that expressed a high level of OIP5-AS1. Further, all 3 lncRNAs harbored interaction sites for miRNAs targeting Yamanaka factors, especially for miR-143/145 suggesting that overexpressed NEAT1, HOTAIR and TUG1 could modulate the post-transcriptional control of the stemness factors by sponging miR-143/145. These transcription factors could in turn bind to the OIP5-AS1 promoter and transactivate the gene resulting in overexpression of OIP5-AS1. Overexpressed OIP5-AS1 may sponge the miRNAs and derepress the target genes CELF1, KMT2A, and KMT2C ( Figure 6 ). Being important players in chromatin modification, deregulated expression of KMT2A, and KMT2C genes may lead to open chromatin configuration resulting in active transcription leading to malignant transformation. Further, NEAT1 was reported to bind active chromatin sites and was significantly accounted for changes in transcriptional activity by binding to TSS [45] . HOTAIR was reported to acts as a scaffold by providing binding surfaces for several chromatin-modifying complexes and to facilitate H3K27/H3K4 methylation and demethylation signatures [46] . Moreover, TUG1 was reported to promote self-renewal of glioma stem cells by sponging miR-145 in the cytoplasm and employing polycomb to repress differentiation genes by locus-specific methylation of histone H3K27 in the nucleus [47] . Therefore, the co-expression of lncRNA NEAT1, HOTAIR and TUG1 has pivotal role not only in sponging stemness TFs targeting miR-143/145 but also interacts with active euchromatins to maintain stemness properties.
In addition, OIP5, the gene harboring OIP5-AS1 gene in antisense orientation, was shown to be overexpressed and significantly associated with several cancers [48] . We, therefore, analyzed the OIP5 gene expression in TCGA HNSCC and observed a significant co-expression with OIP5-AS1.
OIP5 did not share miRNA or TFs that regulates OIP5-AS1 expression level. However, OIP5 was targeted by stemness regulatory miR-143/145, EMT associated miR-200 family and oral cancer-specific tumor suppressor let-7 family. In oral cancer, the expression of OIP5 may not be regulated at the posttranscription level as the miR-143/145, miR-200 and let-7 family microRNAs were reported to be downregulated in oral cancer [9, 11, 14] . These results suggest that with OIP5 gene, lncRNA OIP5-AS1 may play a synergistic role in oral tumorigenesis. In summary, our work presented here showed the significant association of OIP5-AS1 with dedifferentiation pathology in oral tumors. The bioinformatics analysis of lncRNA, miRNA, and mRNA interactions followed by the expression profile identified RNA networks regulating two key chromatin modifiers and one gene involved in the regulation of transcription in oral cancer. Moreover, systematic epigenomic analysis of OIP5-AS1 suggested that the positive transcriptional regulation of OIP5-AS1 by co-expressed NEAT1, TUG1 and HOTAIR by recurring miR-143/145 targeting the stemness associated transcription factors might account for the maintenance of stemness and dedifferentiation in tumors and accounts for poor prognosis. Further functional dissection to ascertain the role of OIP5-AS1 in cellular level is warranted.
Methods
Clinical specimens
The present study was approved by the Institutional Ethics Committee 
RNA isolation and quality control
Extraction of RNA was carried out as described previously [14] . In brief, tissues were washed twice with ice cold PBS to make it free from residual RNA later solution and homogenized using MicroSmash MS-100 automated homogenizer (Tomy, Japan) with Zirconium beads. Total RNA was isolated using the RNAeasy mini kit (Qiagen, Germany) as per the supplier protocol. The RNA was quantified using NanoDrop2000 UV-Vis spectrophotometer (Thermo Scientific, USA) and the integrity of RNA was verified by resolving in 1% agarose gel in Mupid gel electrophoresis (TaKaRa, Japan).
cDNA synthesis and quantitative Real-Time PCR
cDNA synthesis was carried out using total RNA (2 μg for mRNA and lncRNAs and 10 ng for miRNAs) and real-time gene expression analysis was performed in ABI Quantstudio 6K Flex (ABI Life Technology, USA) as described in [14] . The list of gene specific primers and miRNA stem loop primers were presented in Supplementary Table S8 -S10. GAPDH served as an endogenous control for lncRNA and coding genes, and RNU44 as an endogenous control for miRNAs. Each assay was done in triplicate and the expression level was calculated using 2 −ΔΔCt calculation.
Bio-mining for target prediction, gene interactions, and network construction
For gene expression comparison and identification of target genes from the list of predicted genes cancer datasets from TCGA database was analyzed and downloaded using cBioportal and ChIPBase v2. online tools [49] . Predictions of miRNA targets were performed and retrieved from TargetScan, miRanda, miRcode, Starbase and DIANA online prediction tools. For prediction of RNA-RNA interactions and RNA-RNA binding protein (RBPs) interaction, IntaRNA [50] , and CLIPdb [51] online tools were employed. Individual study for assessment of the association of miRNAs in various human cancers was collected from public databases PubMed using MeSH terms such as miRNA/lncRNAs/Gene names, cancer, stemness, EMT, metastasis, prognosis, biomarker, and development. Data from functionally validated studies only were considered for selection of miRNAs and genes. Further, we devised a range of cut-off by reviewing the literature. Hybridization scores for lncRNA-miRNA interaction were calculated using IntaRNA tool. Expression levels and correlation ranking with OIP5-AS1 expression were calculated based on TCGA HNSCC datasets to narrow down the predicted target miRNAs. Chromatin immunoprecipitation (ChIP) data of human embryonic stem cells and cancer cell lines were accessed through ENCODE, Roadmap and ChIPBase v2 database and UCSC genome browser was used to visualize the gene location and transcript graphic maps. RAIN and BioGRID v3.4 databases were used to screen lncRNAs-RNA/Protein interaction network and validated data of protein-protein interaction respectively [52, 53] . Cytoscape v3 was used for visualizing molecular interaction networks.
Statistical analysis
The relationship between clinicopathological characteristic features with expression was examined by Fisher exact test and odds ratio (OR) with 95% confidence interval (CI) was calculated to check the risk association. Differences between the means were presented as means ± SEM and analyzed using Student's t-test (Mann-Whitney) using Graph Pad Prism statistical software, v 6.01 (Graph Pad software Inc, USA). Person correlation test was performed for co-expression analysis and r rank above 0.3 was considered as a significant association. All tests were two-tailed and a P value of <0.05 was considered as statistically significant.
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